High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life.

Reason For The Study: Agitated delirium presents unique challenges for hospice and palliative care clinicians. Haloperidol, the recommended neuroleptic, may be ineffective at low dose, or poorly tolerated at higher doses.

Main Findings: This article reports on two patients with refractory agitated delirium.